| 000 | 01868cam a22003974a 4500 | ||
|---|---|---|---|
| 001 | 15928530 | ||
| 003 | BD-DhUL | ||
| 005 | 20150912115821.0 | ||
| 008 | 090929s2010 njua b 001 0 eng | ||
| 010 | _a 2009040188 | ||
| 015 |
_2bnb _aGBA9A0428 |
||
| 016 | 7 |
_a101516110 _2DNLM |
|
| 016 | 7 |
_a015392203 _2Uk |
|
| 020 | _a9780470257616 (cloth) | ||
| 020 | _a047025761X (cloth) | ||
| 035 | _a(OCoLC)ocn435422355 | ||
| 040 |
_aDNLM/DLC _cDLC _dYDX _dNLM _dBTCTA _dYDXCP _dUKM _dDLC _dDLC |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRM301.25 _b.L433 2010 |
| 060 | 0 | 0 | _a2010 D-768 |
| 060 | 1 | 0 |
_aQV 744 _bL4345 2010 |
| 082 | 0 | 0 |
_a615.19 _222 _bRAL |
| 245 | 0 | 0 |
_aLead generation approaches in drug discovery / _c[edited by] Zoran Rankovic, Richard Morphy. |
| 260 |
_aHoboken, N.J. : _bJohn Wiley, _cc2010. |
||
| 300 |
_axi, 295 p. : _bill. ; _c25 cm. |
||
| 365 |
_aUS$ _b106.15 |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aLead discovery : the process / William F. Michne -- High throughput screening approach to lead discovery / Zoran Rankovic, Craig Jamieson, and Richard Morphy -- In silico screening / Dagmar Stumpfe, Hanna Geppert, and Jürgen Bajorath -- Fragment-based lead discovery / Jeffrey S. Albert -- Design of multitarget ligands / Richard Morphy and Zoran Rankovic -- De novo drug design / Gisbert Schneider, Markus Hartenfeller, Ewgenij Proschak -- Role of natural products in drug discovery / Hugo Lachance, Stefan Wetzel, and Herbert Waldmann -- Early screening for ADMET properties / Dennis A. Smith -- Role of chemistry in lead discovery / Roland E. Dolle and Karin Worm. | |
| 650 | 0 | _aDrug development. | |
| 650 | 0 |
_aDrugs _xDesign. |
|
| 650 | 0 | _aHigh throughput screening (Drug development) | |
| 650 | 1 | 2 |
_aDrug Discovery _xmethods. |
| 700 | 1 | _aRankovic, Zoran. | |
| 700 | 1 | _aMorphy, Richard. | |
| 942 |
_2ddc _cBK |
||
| 999 |
_c41576 _d41576 |
||